CEO Punit Dhillon highlighted significant progress with the clinical development of nimacimab, including the completion of patient enrollment for the CBeyond Phase IIa trial ahead of schedule. The ...

At this year's conference, TransCelerate and representatives from its member companies, including Amgen, Merck, and Pfizer, will participate in seven sessions addressing topics such as data collection ...

In rare disease clinical trials, a comprehensive landscape analysis is essential for identifying the right sites, investigators and patient populations to ensure successful enrollment and retention.

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology provider for modern clinical trials, announces new intelligent automation technology applied across its clinical trials ...

Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options, but are an important part of cancer care at every stage and most aspects ...

OverviewThe global virtual clinical trials market is projected to expand at a steady pace, with an expected growth rate of around 6% over the next five years. This momentum is largely supported by the ...

Decentralized Clinical Trials Market OverviewThe global decentralized clinical trials (DCTs) market is witnessing strong ...